MILPITAS, Calif. — LifeScan on Monday initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately. “Our patients’ ...

Blood samples were obtained from 105 patients during eight days of testing, conducted over a two-week period. Of the 105 patients, 2 were withdrawn from further participation in the study after ...

If you have a meter using the OneTouch Ultra ® or OneTouch Vita ® test strip, you can choose your FREE* meter upgrade. Available in the UK and the Republic of Ireland. All blood glucose meters need to ...

LifeScan, Inc., a Johnson & Johnson company, is recalling a line of its blood glucose meters used by patients with diabetes, because the machines shut off when an "extremely high" blood glucose level ...

LifeScan has announced it is conducting a voluntary recall of eight lots of OneTouch SureStep glucose meter test strips because they may provide falsely low glucose results when the glucose level is ...

OneTouch UltraLink Meter now available Medtronic has introduced the OneTouch UltraLink Meter, a wireless meter that transmits glucose readings directly to MiniMed Paradigm insulin pumps and the ...

LifeScan started in 1981, and most of its products focus on diabetes management. Johnson & Johnson and Platinum Equity are the parent companies of LifeScan. OneTouch claims that 20 million people ...

At extremely high glucose levels (1024 mg/dl and above), the meters will not operate as intended, which could potentially delay the diagnosis and proper treatment of severe hyperglycemia LifeScan, Inc ...

LOS ANGELES, CA / ACCESSWIRE / January 17, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is a 17 year old diabetes focused bio-technology R&D firm, manufacturer, ...

People living with diabetes can now check, manage and share their blood sugar results as conveniently as they check everything else in their lives — wirelessly, on their iPhone, iPad or iPod touch.

Laboratory sheets of adult patients coming to the phlebotomy area of an ambulatory care endocrinology practice were reviewed to identify patients scheduled for a venipuncture for glucose measurement.